secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0000313143-23-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics Q3 fiscal 2023 adjusted EPS $0.82, revenue $298.1M; raises full-year guidance
--------------------------------------------------------------------------------

- Q3 revenue $298.1M (+2.1% reported, -0.1% organic); GAAP EPS $0.37, adjusted EPS $0.82 vs $0.73 prior year.
- Plasma revenue up 3% reported but down 5% organic; Hospital revenue up 12% reported (+7% organic).
- Fiscal 2023 revenue guidance raised to $1.195B-$1.205B; adjusted EPS guidance raised to $3.45-$3.55.
- Nine-month revenue $891.2M (+5.2% reported, +5.9% organic); operating cash flow $157.3M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314323000004/0000313143-23-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314323000004/hae-20230207.htm
  HTML page:      https://secwatch.observer/filing/0000313143-23-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer